Focus Partners Wealth

Position in NBIX — Neurocrine Biosciences Inc

CIK 1542153 ST LOUIS, MO

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,583,332

+$664,593 QoQ

Shares Held

80,335

+14.9% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 62.889151677351094.ToString("F0")% Shared 0.ToString("F0")% None 37.11084832264891.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $54,434,760 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	137,784	$16,287,446
2	NBIX	Neurocrine Biosciences Inc This page	80,335	$10,583,332
3	TAK	Takeda Pharmaceutical Co Ltd	482,387	$8,933,807
4	LNTH	Lantheus Holdings, Inc.	72,517	$5,500,414
5	UTHR	UNITED THERAPEUTICS Corp	5,854	$3,471,304
6	ALKS	Alkermes plc.	77,052	$2,724,558
7	HLN	Haleon plc	195,548	$1,957,435
8	VTRS	Viatris Inc	132,034	$1,783,779

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,583,332	80,335	+14.9%	Shares	Sole	2026-05-15
2025-12-31	$9,918,739	69,934	+6.2%	Shares	Sole	2026-02-13
2025-09-30	$9,240,092	65,822	+15.1%	Shares	Sole	2025-11-14
2025-06-30	$7,186,577	57,177	+13.5%	Shares	Sole	2025-08-14
2025-03-31	$5,573,244	50,391	-1.3%	Shares	Sole	2025-05-20
2024-12-31	$6,972,147	51,078	+9.5%	Shares	Sole	2025-05-29
2024-09-30	$5,375,934	46,658	+1.7%	Shares	Sole	2024-11-14
2024-06-30	$6,315,748	45,876	+0.9%	Shares	Sole	2024-08-15
2024-03-31	$6,272,463	45,479	+12.5%	Shares	Sole	2024-05-16
2023-12-31	$5,325,870	40,421	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.